HPV infections and vaccine attitudes in Slovenian women
Part of Cancer, Infections clinical trials.
This observational study looks at HPV infections and women's views about the HPV vaccine in Slovenia. It aims to understand the characteristics of HPV infections and attitudes toward vaccination after the vaccine became available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman living in Slovenia.
- You have had a regular cervical smear (a test for cells from your cervix) as part of the national screening program, or a follow-up smear after an abnormal result or treatment.
- You are not pregnant at the time of the gynecological exam.
- You do not have menstrual bleeding, vaginal or cervical inflammation, or any other medical condition that would prevent the smear from being taken.
- You have not had your cervix removed (hysterectomy) and have not already had a smear taken for this study.
- You are not allergic to any ingredients in the HPV vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at cervical cancer cases in Spain to learn more about how to prevent it. If you were diagnosed with a common type of cervical cancer between 2019 and 2024, your medical information could help improve prevention efforts.
This study looks at ways to improve cervical cancer prevention for women in Scotland who face extra challenges, such as addiction, homelessness, prison, or sex work. It includes a vaccination and screening part, plus an interview to hear your views.
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
This trial tests whether getting the HPV vaccine after a LEEP (a procedure to remove abnormal cervical cells) can help prevent the abnormal cells from coming back. It's for women who have had high-grade cervical changes or very early cervical cancer.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This study looks at whether HPV vaccination lowers the chance of getting HPV in the cervix. It will collect cervical samples and ask questions to see how vaccination affects infection in women in Sikkim, India.
Hear when a new Cervical Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.